Brinker Capital Investments’s IDEAYA Biosciences IDYA Stock Holding History

Brinker Capital Investments’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.84M	Sell	49,352 -5	-0%	-$153	0.01%	838
2026 Q1	$1.64M	Sell	49,357 -9,037	-15%	-$303K	0.01%	853
2025 Q4	$2.02M	Buy	58,394 +3,962	+7%	+$126K	0.01%	843
2025 Q3	$1.48M	Buy	54,432 +9,807	+22%	+$237K	0.01%	1005
2025 Q2	$938K	Buy	44,625 +8,514	+24%	+$163K	0.01%	1222
2025 Q1	$591K	Buy	36,111 +18,342	+103%	+$391K	0.01%	1337
2024 Q4	$457K	Sell	17,769 -11,784	-40%	-$334K	﹤0.01%	1381
2024 Q3	$936K	Sell	29,553 -5,542	-16%	-$210K	0.01%	1075
2024 Q2	$1.23M	Buy	35,095 +2,485	+8%	+$98.4K	0.01%	885
2024 Q1	$1.43M	Buy	+32,610	New	+$1.4M	0.02%	817

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Brinker Capital Investments's IDYA Position: Q2 2026 in Review

Brinker Capital Investments reduced its IDEAYA Biosciences (IDYA) stake by 0.01% in Q2 2026, selling an estimated $153 and leaving 49,352 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #838.

Brinker Capital Investments first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.02M in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Brinker Capital Investments held 49,352 shares of IDEAYA Biosciences worth $1.84M as of Q2 2026.
Brinker Capital Investments sold 5 IDEAYA Biosciences shares in Q2 2026, an estimated $153.
IDEAYA Biosciences made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #838 holding.
Brinker Capital Investments first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
Brinker Capital Investments's IDEAYA Biosciences position peaked at $2.02M in Q4 2025.
284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.